使用靶标下的超低输入切割在染色质上的单细胞因子定位，并使用核酸酶释放

Executive Industry Relevance

Single-cell uliCUT&RUN enables precise mapping of chromatin-bound factors in ultra-low input samples, addressing a critical bottleneck in early discovery and target validation. This approach supports predictive confidence in regulatory element identification and facilitates mechanistic de-risking for rare or precious biological samples, including those from patient-derived material. Its rapid, scalable workflow positions it as a strategic asset for portfolio triage and translational research continuity.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Enables high-resolution mapping of protein-DNA interactions at the single-cell level for functional target validation.
• Supports mechanistic de-risking by clarifying factor localization in rare or heterogeneous cell populations.
• Facilitates predictive confidence in regulatory element assignment and pathway interrogation.

Screening & Assay Development

• Prepares validated chromatin profiles for downstream screening of transcription factors and chromatin modifiers.
• Delivers quantitative, reproducible readouts suitable for assay standardization and platform scalability.
• Enables reliable evaluation of antibody specificity and sample quality prior to large-scale screening.

Translational & Preclinical Research

• Aligns chromatin factor localization with disease-relevant biomarkers in rare or patient-derived samples.
• Maintains continuity from discovery through preclinical validation by supporting low-input and single-cell workflows.
• Reduces biological risk in translational studies by enabling robust, quantitative chromatin profiling.

Pipeline & Workflow Integration

uliCUT&RUN integrates into the discovery-to-preclinical continuum by enabling hypothesis-driven chromatin mapping from early discovery through lead identification and translational research.

• Discovery Biology: Supports hypothesis testing and pathway clarification by mapping protein-DNA interactions in single cells.
• Screening: Provides quantitative, reproducible chromatin occupancy data for assay readiness and compound evaluation.
• Analytics: Generates high-resolution, antibody-specific enrichment profiles for comparative analysis across conditions.
• Translational Research: Facilitates biomarker alignment and risk-adjusted advancement in rare or precious samples.
• Enterprise Reuse: Offers a scalable, reusable platform for chromatin profiling across diverse biological systems.

Operational & Enterprise Impact

• Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target validation.
• Operational Value: Delivers rapid, standardized, and reproducible workflows for low-input and single-cell samples.
• Strategic Value: Improves go/no-go decision-making and capital efficiency by enabling robust data from limited material.
• Portfolio Impact: Supports risk-adjusted prioritization and advancement of discovery and translational programs.

Implementation Considerations

• Requires expertise in single-cell handling, chromatin biology, and antibody validation.
• Demands access to 96-well magnetic racks, multichannel pipettes, and fragment analysis instrumentation.
• Necessitates rigorous antibody specificity testing and cross-team standardization for reproducibility.
• Adaptable to various cell types but dependent on sample quality and antibody performance.
• Limited by antibody robustness and potential for over-digestion if temperature control is not maintained.

Biopharma FAQs